These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Microalbuminuria is an early marker for increased morbidity and mortality].
    Author: Bramlage P, Wittchen HU, Pittrow D, Dikow R, Kirch W, Lehnert H, Ritz E.
    Journal: Fortschr Med Orig; 2003 Feb 27; 121 Suppl 1():28-32. PubMed ID: 14732947.
    Abstract:
    Recent studies have shown the beneficial effects of a blockade of the renin-angiotensin system (RAS) not only for blood pressure reduction but also end organ protection. One of the markers that is closely correlated with the increased cardiovascular risk is microalbuminuria. A common mediator for the development of both, microalbuminuria and end organ damage seems to be Angiotensin II, the blockade of which apparently reduces microalbuminuria as well as end organ damage. Therefore we had a closer look into pathophysiology of microalbuminuria and the relevance for end organ damage and discuss current medical strategies to alleviate these diseases.
    [Abstract] [Full Text] [Related] [New Search]